Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/16/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 05/06/22
Due: 05/06/23
Phase: N/A
Priority: Normal
Start: 01/05/22
End: 01/31/28
Due: 01/31/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance | NCT06343077 | Ashutosh Kumar Tewari | user2@example.com | None | 2024-01-16 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer | NCT03262103 | Ashutosh Kumar Tewari | user2@example.com | None | 2017-06-16 | 2022-05-06 | 2023-05-06 | - | - | 2025-07-14 |
| The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. | NCT05010200 | Ashutosh Kumar Tewari | user2@example.com | None | 2022-01-05 | 2028-01-31 | 2029-01-31 | - | - | 2025-07-14 |